Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6methyl-2-oxopyridin-1 (2H)-yl)-N,4-dimethylbenzamide

Details for Australian Patent Application No. 2007331199 (hide)

Owner Pfizer Products Inc.

Inventors Vonder Embse, Richard; Yalamanchili, Gopichand; Geurink, Randy; Vanderroest, Ronald; Chekal, Brian; Klemm, George; Mao, Michael; Dukeshereer, Daniel; Vaidyanathan, Rajappa

Agent Shelston IP

Pub. Number AU-A-2007331199

PCT Pub. Number WO2008/072079

Priority 60/869,748 13.12.06 US

Filing date 5 December 2007

Wipo publication date 19 June 2008

International Classifications

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/072079 Priority application(s): WO2008/072079

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007331212-Laser mask for creating a corneal pocket

2007331195-Transferrin fusion protein libraries